Ribometrix, a US-based biotechnology spinout of University of North Carolina at Chapel Hill, has secured $7.5m in a seed round co-led by SV Health Investors and Hatteras Venture Partners.
The round featured Abbvie Ventures and MP Healthcare Venture Management, respective subsidiaries of pharmaceutical firms Abbvie and Mitsubishi Tanabe Pharma, as well as Dementia Discovery Fund and Alexandria Venture Investments, the strategic investment arm of life sciences real estate investment trust Alexandria Real Estate Equities.
RNA drug developer Moderna invested $100,000,…